Loading clinical trials...
Loading clinical trials...
The main objective of the study will be to compare the efficacy of a 2.65 g/day dose of TOTUM-854 versus placebo in decreasing SBP in subjects with high-normal blood pressure and Grade I hypertension ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Valbiotis
Collaborators
NCT05297708 · Elevated Blood Pressure
NCT06669715 · Prehypertension (Elevated Blood Pressure) or Hypertension, Obesity and Obesity-related Medical Conditions
NCT07048509 · Prehypertension (Elevated Blood Pressure) or Hypertension, Healthy
NCT06843577 · Elevated Blood Pressure, Hypertension
NCT05121337 · Elevated Blood Pressure, Hypertension
BioTeSys
Esslingen am Neckar
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions